Perspective: Emerging challenges in the treatment of influenza and parainfluenza in transplant patients

Advances in Virology

Volumn 2011, Issue , 2011, Pages

  Moss, Ronald B ^a   Steigbigel, Roy T ^b   Sanders, Rebecca L ^a   Fang, Fang ^a  

^a NexBio Inc   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARAINFLUENZA VIRUS;

EID: 84872959466     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2011/910930     Document Type: Review

References (74)

1. Leung T. W. C., Tai A. L. S., Cheng P. K. C., Kong M. S. Y., Lim W., Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. Journal of Clinical Virology 2009 46 3 298 299 2-s2.0-72049092943 10.1016/j.jcv.2009.08.004
2. Oseltamivir resistant 2009 pandemic influenza A(H1N1) virus infection in two summer campers receiving prophylaxis- North Carolina, 2009. Morbidity and Mortality Weekly Report 2009 58 35 969 972
3. Suzuki T., Portner A., Scroggs R. A., Uchikawa M., Koyama N., Matsuo K., Suzuki Y., Takimoto T., Receptor specificities of human respiroviruses. Journal of Virology 2001 75 10 4604 4613 10.1128/JVI.75.10.4604-4613.2001 (Pubitemid 32381502)
4. Moscona A., Peluso R. W., Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. Journal of Virology 1991 65 6 2773 2777 2-s2.0-0025941857
5. Ito T., Interspecies transmission and receptor recognition of influenza A viruses. Microbiology and Immunology 2000 44 6 423 430 2-s2.0-0033947283 (Pubitemid 30431762)
6. Boeckh M., The challenge of respiratory virus infections in hematopoietic cell transplant recipients. British Journal of Haematology 2008 143 4 455 467 2-s2.0-54849442703 10.1111/j.1365-2141.2008.07295.x
7. Kunisaki K. M., Janoff E. N., Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. The Lancet Infectious Diseases 2009 9 8 493 504 2-s2.0-67650626749 10.1016/S1473-3099(09)70175-6
8. Issa N. C., Marty F. M., Gagne L. S., Koo S., Verrill K. A., Alyea E. P., Cutler C. S., Koreth J., Armand P., Ho V. T., Antin J. H., Soiffer R. J., Baden L. R., Seroprotective titers against 2009 H1N1 influenza a virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biology of Blood and Marrow Transplantation 2010 17 3 434 438 2-s2.0-78649593693 10.1016/j.bbmt.2010.10.002
9. Ison M. G., Hayden F. G., Viral infections in immunocompromised patients: what's new with respiratory viruses? Current Opinion in Infectious Diseases 2002 15 4 355 367 2-s2.0-0036324942 (Pubitemid 34816423)
10. Nichols W. G., Guthrie K. A., Corey L., Boeckh M., Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clinical Infectious Diseases 2004 39 9 1300 1306 2-s2.0-7644229250 10.1086/425004 (Pubitemid 39458515)
11. Kumar D., Humar A., Respiratory viral infections in transplant and oncology patients. Infectious Disease Clinics of North America 2010 24 2 395 412 2-s2.0-77952723344 10.1016/j.idc.2010.01.007
12. Martino R., Porras R. P., Rabella N., Williams J. V., Rámila E., Margall N., Labeaga R., Crowe J. E., Coll P., Sierra J., Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses is adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biology of Blood and Marrow Transplantation 2005 11 10 781 796 2-s2.0-26044476179 10.1016/j.bbmt.2005.07.007 (Pubitemid 41403760)
13. Boivin G., Goyette N., Bernatchez H., Prolonged excretion of amantadine-resistant influenza A virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Clinical Infectious Diseases 2002 34 5 E23 E25
14. Klimov A. I., Rocha E., Hayden F. G., Shult P. A., Roumillat L. F., Cox N. J., Prolonged shedding of amantadine-resistant influenza A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. Journal of Infectious Diseases 1995 172 5 1352 1355
15. Gooskens J., Jonges M., Claas E. C. J., Meijer A., Kroes A. C. M., Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. Journal of Infectious Diseases 2009 199 10 1435 1441 2-s2.0-65549170088 10.1086/598684
16. Boivin G., Goyette N., Bernatchez H., Prolonged excretion of amantadine-resistant influenza A virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Clinical Infectious Diseases 2002 34 5 E23 E25 2-s2.0-19044366154
17. Gooskens J., j.gooskens@lumc.nl Jonges M., Claas E. C. J., Meijer A., van den Broek P. J., Kroes A. C. M., Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. Journal of the American Medical Association 2009 301 10 1042 1046 10.1001/jama.2009.297
18. Shinde V., Bridges C. B., Uyeki T. M., Shu B., Balish A., Xu X., Lindstrom S., Gubareva L. V., Deyde V., Garten R. J., Harris M., Gerber S., Vagasky S., Smith F., Pascoe N., Martin K., Dufficy D., Ritger K., Conover C., Quinlisk P., Klimov A., Bresee J. S., Finelli L., lfinelli@cdc.gov Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. The New England Journal of Medicine 2009 360 25 2616 2625 10.1056/NEJMoa0903812
19. Dawood F. S., fdawood@cdc.gov Jain S., Finelli L., Shaw M. W., mshaw1@cdc.gov Lindstrom S., Garten R. J., Gubareva L. V., Xu X., Bridges C. B., Uyeki T. M., Emergence of a novel swine-origin influenza A (H1N1) virus in humans. The New England Journal of Medicine 2009 360 25 2605 2615 10.1056/NEJMoa0903810
20. Rungrotmongkol T., Intharathep P., Malaisree M., Nunthaboot N., Kaiyawet N., Sompornpisut P., Payungporn S., Poovorawan Y., Hannongbua S., Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Biochemical and Biophysical Research Communications 2009 385 3 390 394 2-s2.0-67349211850 10.1016/j.bbrc.2009.05.066
21. http://www.who.int/csr/disease/swineflu/oseltamivirresistant20100820.pdf
22. Barr I. G., Cui L., Komadina N., Lee R. T., Lin R. T., Deng Y., Caldwell N., Shaw R., Maurer-Stroh S., A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Eurosurveillance 2010 15 42 1 6 2-s2.0-78049506703
23. Moss R. B., Davey R. T., Steigbigel R. T., Fang F., Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. Journal of Antimicrobial Chemotherapy 2010 65 6 1086 1093 2-s2.0-77953517101 10.1093/jac/dkq100
24. Kumar D., Michaels M. G., Morris M. I., Green M., Avery R. K., Liu C., Danziger-Isakov L., Stosor V., Estabrook M., Gantt S., Marr K. A., Martin S., Silveira F. P., Razonable R. R., Allen U. D., Levi M. E., Lyon G. M., Bell L. E., Huprikar S., Patel G., Gregg K. S., Pursell K., Helmersen D., Julian K. G., Shiley K., Bono B., Dharnidharka V. R., Alavi G., Kalpoe J. S., Shoham S., Reid G. E., Humar A., Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. The Lancet Infectious Diseases 2010 10 8 521 526 2-s2.0-77955096526 10.1016/S1473-3099(10)70133-X
25. Espinosa-Aguilar L., Green J. S., Forrest G. N., Ball E. D., Maziarz R. T., Strasfeld L., Taplitz R. A., Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences. Biology of Blood and Marrow Transplantation 2011 17 4 566 573 2-s2.0-77956804663 10.1016/j.bbmt.2010. 07.018
26. George B., Ferguson P., Kerridge I., Gilroy N., Gottlieb D., Hertzberg M., The clinical impact of infection with swine flu (H1N109) strain of influenza virus in hematopoietic stem cell transplant recipients. Biology of Blood and Marrow Transplantation 2011 17 1 147 153
27. Antón A., ananton@clinic.ub.es López-Iglesias A. A., Tórtola T., Ruiz-Camps I., Abrisqueta P., Llopart L., Marcos M. Á., Martínez M. J., Tudó G., Bosch F., Pahissa A., de Anta M. T. J., Pumarola T., Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors. Diagnostic Microbiology and Infectious Disease 2010 68 3 214 219 10.1016/j.diagmicrobio.2010.08.003
28. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington, 2009. Morbidity and Mortality Weekly Report 2009 58 893 896
29. Memoli M. J., memolim@niaid.nih.gov Hrabal R. J., Hassantoufighi A., Eichelberger M. C., Taubenberger J. K., Rapid selection of oseltamivirand peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clinical Infectious Diseases 2010 50 9 1252 1255 10.1086/651605
30. van der Vries E., Stelma F. F., Boucher C. A. B., Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. The New England Journal of Medicine 2010 363 14 1381 1382 2-s2.0-77957330207 10.1056/NEJMc1003749
31. Renaud C., Pergam S. A., Polyak C., Jain R., Kuypers J., Englund J. A., Corey L., Boeckh M. J., Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir. Transplant Infectious Disease 2010 12 6 513 517 2-s2.0-78650078076 10.1111/j.1399-3062. 2010.00582.x
32. Redelman-Sidi G., Sepkowitz K. A., Huang C. K., Park S., Stiles J., Eagan J., Perlin D. S., Pamer E. G., Kamboj M., 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. The Journal of Infection 2010 60 4 257 263 2-s2.0-77951779220
33. Moore C., Galiano M., Lackenby A., Abdelrahman T., Barnes R., Evans M. R., Fegan C., Froude S., Hastings M., Knapper S., Litt E., Price N., Salmon R., Temple M., Davies E., eleri.davies4@wales.nhs.uk Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza a(H1N1) 2009 virus in a hematology unit. Journal of Infectious Diseases 2011 203 1 18 24 10.1093/infdis/jiq007
34. Kidd I. M., Down J., Nastouli E., Shulman R., Grant P. R., Howell D. C., Singer M., H1N1 pneumonitis treated with intravenous zanamivir. The Lancet 2009 374 9694 1036 2-s2.0-70249109183 10.1016/S0140-6736(09)61528-2
35. Khanna N., Steffen I., Studt J. D., Schreiber A., Lehmann T., Weisser M., Flückiger U., Gratwohl A., Halter J., Hirsch H. H., Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease 2009 11 2 100 105 2-s2.0-64249135712 10.1111/j.1399-3062.2008.00362.x
36. Relenza:Highlights of prescribing information,. http://www.cdc.gov/ h1n1flu/eua/pdf/relenza-packageinsert.pdf
37. http://www.cdc.gov/H1N1flu/recommendations.htm
38. Moscona A., Global transmission of oseltamivir-resistant influenza. The New England Journal of Medicine 2009 360 10 953 956 2-s2.0-61849118968 10.1056/NEJMp0900648
39. http://www.cdc.gov/h1n1flu/immunosuppression/index.htm
40. Sheu T. G., Fry A. M., Garten R. J., Deyde V. M., Shwe T., Bullion L., Peebles P. J., Li Y., Klimov A. I., Gubareva L. V., lgubareva@cdc.gov Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. Journal of Infectious Diseases 2011 203 1 13 17 10.1093/infdis/jiq005
41. Chan-Tack K. M., Murray J. S., Birnkrant D. B., Use of ribavirin to treat influenza. The New England Journal of Medicine 2009 361 17 1713 1714 2-s2.0-70350322696 10.1056/NEJMc0905290
42. Gaur A. H., Bagga B., Barman S., Hayden R., Lamptey A., Hoffman J. M., Bhojwani D., Flynn P. M., Tuomanen E., Webby R., Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. The New England Journal of Medicine 2010 362 1 88 89 2-s2.0-74049115877 10.1056/NEJMc0910893
43. Duval X., van der Werf S., Blanchon T., Mosnier A., Bouscambert-Duchamp M., Tibi A., Enouf V., Charlois-Ou C., Vincent C., Andreoletti L., Tubach F., Lina B., Mentré F., Leport C., Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Medicine 2010 7 11 e1000362 10.1371/journal.pmed. 1000362
44. Smee D. F., Hurst B. L., Egawa H., Takahashi K., Kadota T., Furuta Y., Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells. Journal of Antimicrobial Chemotherapy 2009 64 4 741 746 2-s2.0-70349443188 10.1093/jac/dkp274
45. Furuta Y., Takahashi K., Shiraki K., Sakamoto K., Smee D. F., Barnard D. L., Gowen B. B., Julander J. G., Morrey J. D., T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Research 2009 82 3 95 102 2-s2.0-64749093901 10.1016/j.antiviral.2009.02.198
46. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., Muramoto Y., Tamura D., Sakai-Tagawa Y., Noda T., Sakabe S., Imai M., Hatta Y., Watanabe S., Li C., Yamada S., Fujii K., Murakami S., Imai H., Kakugawa S., Ito M., Takano R., Iwatsuki-Horimoto K., Shimojima M., Horimoto T., Goto H., Takahashi K., Makino A., Ishigaki H., Nakayama M., Okamatsu M., Takahashi K., Warshauer D., Shult P. A., Saito R., Suzuki H., Furuta Y., Yamashita M., Mitamura K., Nakano K., Nakamura M., Brockman-Schneider R., Mitamura H., Yamazaki M., Sugaya N., Suresh M., Ozawa M., Neumann G., Gern J., Kida H., Ogasawara K., Kawaoka Y., In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009 460 7258 1021 1025 2-s2.0-69149093400 10.1038/nature08260
47. Sleeman K., Mishin V. P., Deyde V. M., Furuta Y., Klimov A. I., Gubareva L. V., LGubareva@cdc.gov In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrobial Agents and Chemotherapy 2010 54 6 2517 2524 10.1128/AAC.01739-09
48. Kiso M., Takahashi K., Sakai-Tagawa Y., Shinya K., Sakabe S., Le Q. M., Ozawa M., Furuta Y., Kawaoka Y., T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proceedings of the National Academy of Sciences of the United States of America 2010 107 2 882 887 2-s2.0-76249125006 10.1073/pnas.0909603107
49. Malakhov M. P., Aschenbrenner L. M., Smee D. F., Wandersee M. K., Sidwell R. W., Gubareva L. V., Mishin V. P., Hayden F. G., Kim D. H., Ing A., Campbell E. R., Yu M., Fang F., Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrobial Agents and Chemotherapy 2006 50 4 1470 1479 2-s2.0-33645765519 10.1128/AAC.50.4.1470-1479.2006
50. Belser J. A., Lu X., Szretter K. J., Jin X., Aschenbrenner L. M., Lee A., Hawley S., Do H. K., Malakhov M. P., Yu M., Fang F., Katz J. M., DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza h5N1 virus infection. Journal of Infectious Diseases 2007 196 10 1493 1499 2-s2.0-38449093101 10.1086/522609 (Pubitemid 351411986)
51. Triana-Baltzer G. B., Gubareva L. V., Klimov A. I., Wurtman D. F., Moss R. B., Hedlund M., Larson J. L., Belshe R. B., Fang F., Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS One 2009 4 11 2-s2.0-70450198610 10.1371/journal.pone. 0007838 e7838
52. Triana-Baltzer G. B., Gubareva L. V., Nicholls J. M., Pearce M. B., Mishin V. P., Belser J. A., Chen L. M., Chan R. W. Y., Chan M. C. W., Hedlund M., Larson J. L., Moss R. B., Katz J. M., Tumpey T. M., Fang F., Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS One 2009 4 11 2-s2.0-70450175741 10.1371/journal.pone.0007788 e7788
53. Nichols W. G., Peck Campbell A. J., Boeckh M., Respiratory viruses other than influenza virus: impact and therapeutic advances. Clinical Microbiology Reviews 2008 21 2 274 290 2-s2.0-42349098907 10.1128/CMR.00045-07 (Pubitemid 351555508)
54. Henrickson K. J., Parainfluenza viruses. Clinical Microbiology Reviews 2003 16 2 242 264 2-s2.0-0037396962 10.1128/CMR.16.2.242-264.2003 (Pubitemid 36519811)
55. Denny F. W., Clyde W. A. Jr., Acute lower respiratory tract infections in nonhospitalized children. Journal of Pediatrics 1986 108 5 635 646 2-s2.0-0022885642 (Pubitemid 16064102)
56. Glezen W. P., Frank A. L., Taber L. H., Kasel J. A., Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. Journal of Infectious Diseases 1984 150 6 851 857 2-s2.0-0021710556 (Pubitemid 15182138)
57. Shay D. K., Holman R. C., Newman R. D., Liu L. L., Stout J. W., Anderson L. J., Bronchiolitis-associated hospitalizations among US children, 1980-1996. Journal of the American Medical Association 1999 282 15 1440 1446 2-s2.0-0032696770 10.1001/jama.282.15.1440 (Pubitemid 29493797)
58. Peck A. J., Englund J. A., Kuypers J., Guthrie K. A., Corey L., Morrow R., Hackman R. C., Cent A., Boeckh M., Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 2007 110 5 1681 1688 2-s2.0-34548861752 10.1182/blood-2006-12-060343 (Pubitemid 47443987)
59. Boeckh M., The challenge of respiratory virus infections in hematopoietic cell transplant recipients. British Journal of Haematology 2008 143 4 455 467 2-s2.0-54849442703 10.1111/j.1365-2141.2008.07295.x
60. Kumar D., Humar A., Respiratory viral infections in transplant and oncology patients. Infectious Disease Clinics of North America 2010 24 2 395 412 2-s2.0-77952723344 10.1016/j.idc.2010.01.007
61. Vilchez R. A., Dauber J., McCurry K., Iacono A., Kusne S., Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function. American Journal of Transplantation 2003 3 2 116 120 2-s2.0-0037298129 10.1034/j.1600-6143.2003. 00024.x (Pubitemid 36323108)
62. Vilchez R. A., McCurry K., Dauber J., Iacono A., Keenan R., Zeevi A., Griffith B., Kusne S., The epidemiology of parainfluenza virus infection in lung transplant recipients. Clinical Infectious Diseases 2001 33 12 2004 2008 2-s2.0-0035893115 10.1086/324348 (Pubitemid 33152394)
63. Billings J. L., Hertz M. I., Savik K., Wendt C. H., Respiratory viruses and chronic rejection in lung transplant recipients. Journal of Heart and Lung Transplantation 2002 21 5 559 566 2-s2.0-0036248179 10.1016/S1053-2498(01)00405- 3 (Pubitemid 34451028)
64. Henrickson K. J., Parainfluenza viruses. Clinical Microbiology Reviews 2003 16 2 242 264 2-s2.0-0037396962 10.1128/CMR.16.2.242-264.2003 (Pubitemid 36519811)
65. Maziarz R. T., Sridharan P., Slater S., Meyers G., Post M., Erdman D. D., Peret T. C. T., Taplitz R. A., Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients. Biology of Blood and Marrow Transplantation 2010 16 2 192 198 2-s2.0-75149122733 10.1016/j.bbmt.2009. 09.014
66. Chakrabarti S., Collingham K. E., Holder K., Fegan C. D., Osman H., Milligan D. W., Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. Bone Marrow Transplantation 2001 28 8 759 763 2-s2.0-0035176383 10.1038/sj.bmt.1703216 (Pubitemid 33085568)
67. Chakrabarti S., Avivi I., Mackinnon S., Ward K., Kottaridis P. D., Osman H., Waldmann H., Hale G., Fegan C. D., Yong K., Goldstone A. H., Linch D. C., Milligan D. W., Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. British Journal of Haematology 2002 119 4 1125 1132 2-s2.0-18744405985 10.1046/j.1365-2141.2002.03992.x (Pubitemid 35463842)
68. Nichols W. G., gnichols@fhcrc.org Gooley T., Boeckh M., Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biology of Blood and Marrow Transplantation 2001 7 12, supplement 1 11S 15S (Pubitemid 33734763)
69. Liu V., Dhillon G. S., Weill D., A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Transplant Infectious Disease 2010 12 1 38 44 2-s2.0-77149126220 10.1111/j.1399-3062.2009.00453.x
70. Amonsen M., Smith D. F., Cummings R. D., Air G. M., Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with α 2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin. Journal of Virology 2007 81 15 8341 8345 2-s2.0-34547114495 10.1128/JVI.00718-07 (Pubitemid 47101519)
71. Moscona A., Anm2047@med.cornell.edu Porotto M., Palmer S., Tai C., Aschenbrenner L., Triana-Baltzer G., Li Q.-X., Wurtman D., Niewiesk S., Fang F., ffang@nexbio.com A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo. Journal of Infectious Diseases 2010 202 2 234 241 10.1086/653621
72. Chen Y. B., Driscoll J., McAfee S. L., Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation. Poster Presented at Annual Meeting of American Society for Blood and Bone Marrow Transplantation February 2011
73. Karron R. A., rkarron@jhsph.edu Belshe R. B., Wright P. F., Thumar B., Burns B., Newman F., Cannon J. C., Thompson J., Tsai T., Paschalis M., Wu S.-L., Mitcho Y., Hackell J., Murphy B. R., Tatem J. M., A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants. Pediatric Infectious Disease Journal 2003 22 5 394 405 10.1097/00006454-200305000-00002 (Pubitemid 36578739)
74. Sato M., Wright P. F., Current status of vaccines for parainfluenza virus infections. The Pediatric Infectious Disease Journal 2008 27 10 S123 125 2-s2.0-56149084169